SecProbe.io

Filing text and metadata
Intelligence Terminal Search Topics Monthly Activity About

Correspondence 0001104659-24-127184 from Anteris Technologies Global Corp. (AVR) (CIK 0002011514) (AVR)

Anteris Technologies Global Corp. (AVR) (CIK 0002011514)
Date: Dec. 10, 2024 · CIK: 0002011514 · Accession: 0001104659-24-127184

AI Filing Summary & Sentiment

File numbers found in text: 333-283414

Date
December 10, 2024
Author
TD SECURITIES (USA) LLC
Form
CORRESP
Company
Anteris Technologies Global Corp. (AVR) (CIK 0002011514)

Letter

TD Securities (USA) LLC

1 Vanderbilt Avenue

New York, New York 10017

Barclays Capital Inc.

745 Seventh Avenue

New York, NY 10019

Cantor Fitzgerald & Co.

110 East 59th Street, 6th Floor

New York, NY 10022

December 10, 2024

VIA EDGAR

U.S. Securities and Exchange Commission

Division of Corporation Finance

Office of Life Sciences

100 F Street, N.E.

Washington, D.C. 20549-3720

Re: Anteris Technologies Global Corp.

Registration Statement on Form S-1, as amended

File No. 333-283414

Request for Acceleration of Effective Date

Ladies and Gentlemen:

In accordance with Rule 461 under the Securities Act of 1933, as amended (the “Act”), we, as representatives of the several underwriters, hereby join in the request of Anteris Technologies Global Corp. (the “Company”) for acceleration of the effective date of the above-referenced Registration Statement on Form S-1 so that it becomes effective as of 4:00 p.m. Eastern time on December 12, 2024, or as soon thereafter as practicable, or at such other time as the Company or its outside counsel, Jones Day, orally request that such Registration Statement be declared effective.

Pursuant to Rule 460 under the Act, we, as representatives of the several underwriters, wish to advise you that there will be distributed to each underwriter or dealer, who is reasonably anticipated to participate in the distribution of the security, as many copies of the proposed form of preliminary prospectus as appears to be reasonable to secure adequate distribution of the preliminary prospectus.

We, the undersigned, as representatives of the several underwriters, have complied and will comply, and we have been informed by the participating underwriters that they have complied and will comply, with the requirements of Rule 15c2-8 under the Securities Exchange Act of 1934, as amended.

[Remainder of Page Intentionally Left Blank; Signature Page Follows]

Very truly yours,
TD SECURITIES (USA) LLC

Show Raw Text
CORRESP
1
filename1.htm

TD Securities (USA) LLC

1 Vanderbilt Avenue

New York, New York 10017

Barclays Capital Inc.

745 Seventh
Avenue

New York, NY 10019

Cantor Fitzgerald & Co.

110 East 59th Street, 6th Floor

New York, NY 10022

December 10, 2024

VIA EDGAR

U.S. Securities and Exchange Commission

Division
of Corporation Finance

Office of Life Sciences

100 F Street, N.E.

Washington, D.C.
20549-3720

Re: Anteris Technologies Global
Corp.

  Registration Statement on Form S-1, as amended

  File No. 333-283414

  Request for Acceleration of Effective Date

Ladies and Gentlemen:

In accordance
with Rule 461 under the Securities Act of 1933, as amended (the “Act”), we, as representatives of the several underwriters,
hereby join in the request of Anteris Technologies Global Corp. (the “Company”) for acceleration of the effective date
of the above-referenced Registration Statement on Form S-1 so that it becomes effective as of 4:00 p.m. Eastern time on December 12, 2024,
or as soon thereafter as practicable, or at such other time as the Company or its outside counsel, Jones Day, orally request that such
Registration Statement be declared effective.

Pursuant to Rule
460 under the Act, we, as representatives of the several underwriters, wish to advise you that there will be distributed to each underwriter
or dealer, who is reasonably anticipated to participate in the distribution of the security, as many copies of the proposed form of preliminary
prospectus as appears to be reasonable to secure adequate distribution of the preliminary prospectus.

We, the undersigned,
as representatives of the several underwriters, have complied and will comply, and we have been informed by the participating underwriters
that they have complied and will comply, with the requirements of Rule 15c2-8 under the Securities Exchange Act of 1934, as amended.

[Remainder
of Page Intentionally Left Blank; Signature Page Follows]

Very truly yours,

TD SECURITIES (USA) LLC

BARCLAYS CAPITAL INC.

CANTOR
FITZGERALD & CO.

For themselves and on behalf of the

several Underwriters
listed

in Schedule A of the Underwriting Agreement

TD SECURITIES (USA) LLC

By: /s/ Michael Campbell

Name: Michael Campbell

Title: Managing Director

BARCLAYS CAPITAL INC.

By: /s/ Dan Cocks

Name: Dan Cocks

Title: Managing Director

CANTOR FITZGERALD & CO.

By: /s/ Jason Fenton

Name: Jason Fenton

Title: Global Co-Head of ECM